home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 27, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries


5805 State Bridge Rd, Suite G 414
Johns Creek
United States of America, Georgia
Toll free: 855.698.6988

Phone: 615.397.9545
Fax: 855.698.6998

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


ABBIOSCI Inc. specializes in the production, detection and characterization of multi-format antibodies (MFAbs) for research, diagnostic, and therapeutic applications. MFAbs includes polyclonal antibodies (pAb), monoclonal antibodies (mAb), recombinant antibodies (rAb), and antibody engineering fragments (Ab-Eng). Monoclonal antibody is made specifically to recognize a single epitope on an antigen. We also offer overlapping synthetic peptides derived from dengue virus type 1-envelope proteins. Antibody engineering is the efficient way to create a functional antibody with a suitable size by using DNA recombinant technology. Antibody gene can be purposely engineered or modified in vitro to obtain a desirable antibody with biological activity.


Visit our website for further information: www.abbiosci.com 

Selected Categories:
Product Company   Service Company
- General
- Research
- Immunoassay
- in vitro

Last update of this entry: February 23, 2012

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.